AHR signaling in prostate growth, morphogenesis, and disease

Biochemical Pharmacology

Volumn 77, Issue 4, 2009, Pages 566-576

  Vezina, Chad M ^a   Lin, Tien Min ^a   Peterson, Richard E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANDROGEN; ANDROGEN RECEPTOR; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450; ESTROGEN; ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR 10; RETINOIC ACID; VASCULOTROPIN; WNT5A PROTEIN;

AGING; DISEASE PREDISPOSITION; EMBRYO PATTERN FORMATION; ENZYME INDUCTION; FETUS DEVELOPMENT; HUMAN; MORPHOGENESIS; NONHUMAN; ONTOGENY; ORGAN GROWTH; PRIORITY JOURNAL; PROSTATE; PROSTATE DISEASE; PROTEIN PROTEIN INTERACTION; REPRODUCTIVE TOXICITY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ENVIRONMENTAL POLLUTANTS; HUMANS; MALE; ORGANOGENESIS; PROSTATE; PROSTATIC DISEASES; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, STEROID; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN;

EID: 59149086440     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.09.039     Document Type: Review

References (98)

1. Cunha G.R., and Chung L.W. Stromal-epithelial interactions--I. Induction of prostatic phenotype in urothelium of testicular feminized (Tfm/y) mice. J Steroid Biochem 14 (1981) 1317-1324
2. Cunha G.R., and Lung B. The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice. J Exp Zool 205 (1978) 181-193
3. Lin T.M., Rasmussen N.T., Moore R.W., Albrecht R.M., and Peterson R.E. Region-specific inhibition of prostatic epithelial bud formation in the urogenital sinus of C57BL/6 mice exposed in utero to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Sci 76 (2003) 171-181
4. Timms B.G., Mohs T.J., and Didio L.J. Ductal budding and branching patterns in the developing prostate. J Urol 151 (1994) 1427-1432
5. Sugimura Y., Cunha G.R., and Donjacour A.A. Morphogenesis of ductal networks in the mouse prostate. Biol Reprod 34 (1986) 961-971
6. Marker P.C., Donjacour A.A., Dahiya R., and Cunha G.R. Hormonal, cellular, and molecular control of prostatic development. Dev Biol 253 (2003) 165-174
7. Signoretti S., and Loda M. Defining cell lineages in the prostate epithelium. Cell Cycle 5 (2006) 138-141
8. Sommer R.J., Sojka K.M., Pollenz R.S., Cooke P.S., and Peterson R.E. Ah receptor and ARNT protein and mRNA concentrations in rat prostate: effects of stage of development and 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment. Toxicol Appl Pharmacol 155 (1999) 177-189
9. Kashani M., Steiner G., Haitel A., Schaufler K., Thalhammer T., Amann G., et al. Expression of the aryl hydrocarbon receptor (AhR) and the aryl hydrocarbon receptor nuclear translocator (ARNT) in fetal, benign hyperplastic, and malignant prostate. Prostate 37 (1998) 98-108
10. Lin T.M., Ko K., Moore R.W., Buchanan D.L., Cooke P.S., and Peterson R.E. Role of the aryl hydrocarbon receptor in the development of control and 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed male mice. J Toxicol Environ Health A 64 (2001) 327-342
11. Mably T.A., Moore R.W., and Peterson R.E. In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. effects on androgenic status. Toxicol Appl Pharmacol 114 (1992) 97-107
12. Gray L.E., Ostby J.S., and Kelce W.R. A dose-response analysis of the reproductive effects of a single gestational dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin in male Long Evans Hooded rat offspring. Toxicol Appl Pharmacol 146 (1997) 11-20
13. Simanainen U., Adamsson A., Tuomisto J.T., Miettinen H.M., Toppari J., Tuomisto J., et al. Adult 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure and effects on male reproductive organs in three differentially TCDD-susceptible rat lines. Toxicol Sci 81 (2004) 401-407
14. Theobald H.M., and Peterson R.E. In utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-rho-dioxin: effects on development of the male and female reproductive system of the mouse. Toxicol Appl Pharmacol 145 (1997) 124-135
15. Lin T.M., Ko K., Moore R.W., Simanainen U., Oberley T.D., and Peterson R.E. Effects of aryl hydrocarbon receptor null mutation and in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on prostate and seminal vesicle development in C57BL/6 mice. Toxicol Sci 68 (2002) 479-487
16. Thomas R.S., Penn S.G., Holden K., Bradfield C.A., and Rank D.R. Sequence variation and phylogenetic history of the mouse Ahr gene. Pharmacogenetics 12 (2002) 151-163
17. Lin T.M., Simanainen U., Moore R.W., and Peterson R.E. Critical windows of vulnerability for effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on prostate and seminal vesicle development in C57BL/6 mice. Toxicol Sci 69 (2002) 202-209
18. Ko K., Theobald H.M., and Peterson R.E. In utero and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the C57BL/6J mouse prostate: lobe-specific effects on branching morphogenesis. Toxicol Sci 70 (2002) 227-237
19. Cunha G.R. The role of androgens in the epithelio-mesenchymal interactions involved in prostatic morphogenesis in embryonic mice. Anat Rec 175 (1973) 87-96
20. Vezina C.M., Allgeier S., Moore R., Lin T.-M., Bemis J., Hardin H.A., et al. Dioxin Causes Ventral Prostate Agenesis by Disrupting Dorsoventral Patterning in Developing Mouse Prostate. Toxicol Sci 106 (2008) 488-496
21. Lin T.M., Rasmussen N.T., Moore R.W., Albrecht R.M., and Peterson R.E. 2,3,7,8-tetrachlorodibenzo-p-dioxin inhibits prostatic epithelial bud formation by acting directly on the urogenital sinus. J Urol 172 (2004) 365-368
22. Ko K., Moore R.W., and Peterson R.E. Aryl hydrocarbon receptors in urogenital sinus mesenchyme mediate the inhibition of prostatic epithelial bud formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 196 (2004) 149-155
23. Cunha G.R., Cooke P.S., and Kurita T. Role of stromal-epithelial interactions in hormonal responses. Arch Histol Cytol 67 (2004) 417-434
24. Boverhof D.R., Kwekel J.C., Humes D.G., Burgoon L.D., and Zacharewski T.R. Dioxin induces an estrogen-like, estrogen receptor-dependent gene expression response in the murine uterus. Mol Pharmacol 69 (2006) 1599-1606
25. Gray L.E., Ostby J., Furr J., Wolf C.J., Lambright C., Parks L., et al. Effects of environmental antiandrogens on reproductive development in experimental animals. Hum Reprod Update 7 (2001) 248-264
26. Jana N.R., Sarkar S., Ishizuka M., Yonemoto J., Tohyama C., and Sone H. Cross-talk between 2,3,7,8-tetrachlorodibenzo-p-dioxin and testosterone signal transduction pathways in LNCaP prostate cancer cells. Biochem Biophys Res Commun 256 (1999) 462-468
27. Safe S., and Wormke M. Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action. Chem Res Toxicol 16 (2003) 807-816
28. Ko K., Theobald H.M., Moore R.W., and Peterson R.E. Evidence that inhibited prostatic epithelial bud formation in 2,3,7,8-tetrachlorodibenzo-p-dioxin-exposed C57BL/6J fetal mice is not due to interruption of androgen signaling in the urogenital sinus. Toxicol Sci 79 (2004) 360-369
29. Timms B.G., Howdeshell K.L., Barton L., Bradley S., Richter C.A., and vom Saal F.S. Estrogenic chemicals in plastic and oral contraceptives disrupt development of the fetal mouse prostate and urethra. Proc Natl Acad Sci U S A 102 (2005) 7014-7019
30. Coveney D., Shaw G., and Renfree M.B. Effects of oestrogen treatment on testicular descent, inguinal closure and prostatic development in a male marsupial, Macropus eugenii. Reproduction 124 (2002) 73-83
31. vom Saal F.S., Timms B.G., Montano M.M., Palanza P., Thayer K.A., Nagel S.C., et al. Prostate enlargement in mice due to fetal exposure to low doses of estradiol or diethylstilbestrol and opposite effects at high doses. Proc Natl Acad Sci U S A 94 (1997) 2056-2061
32. Hicks S.M., Lin T.-M., Mukai M., Cooke P.S., and Peterson R.E. Estrogen receptor alpha is not required for normal prostatic bud formation or for inhibition of prostatic bud formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice. Toxicologist (Suppl Toxicol Sci) 84 (2005) 554
33. Uno S., Dalton T.P., Sinclair P.R., Gorman N., Wang B., Smith A.G., et al. Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria. Toxicol Appl Pharmacol 196 (2004) 410-421
34. Uno S., Dalton T.P., Shertzer H.G., Genter M.B., Warshawsky D., Talaska G., et al. Benzo[a]pyrene-induced toxicity: paradoxical protection in Cyp1a1(-/-) knockout mice having increased hepatic BaP-DNA adduct levels. Biochem Biophys Res Commun 289 (2001) 1049-1056
35. Takemoto K., Nakajima M., Fujiki Y., Katoh M., Gonzalez F.J., and Yokoi T. Role of the aryl hydrocarbon receptor and Cyp1b1 in the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch Toxicol 78 (2004) 309-315
36. Heidel S.M., Holston K., Buters J.T., Gonzalez F.J., Jefcoate C.R., and Czupyrynski C.J. Bone marrow stromal cell cytochrome P4501B1 is required for pre-B cell apoptosis induced by 7,12-dimethylbenz[a]anthracene. Mol Pharmacol 56 (1999) 1317-1323
37. Buters J.T., Sakai S., Richter T., Pineau T., Alexander D.L., Savas U., et al. Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]anthracene-induced lymphomas. Proc Natl Acad Sci U S A 96 (1999) 1977-1982
38. Allgeier S.H., Lin T.-M., Vezina C.M., Moore R.W., Fritz W.A., Chiu S.-Y., et al. WNT5A Selectively Inhibits Mouse Ventral Prostate Development. Developmental Biology. Dev Biol 324 (2008) 10-17
39. Donjacour A.A., Thomson A.A., and Cunha G.R. FGF-10 plays an essential role in the growth of the fetal prostate. Dev Biol 261 (2003) 39-54
40. Vezina C.M., Allgeier S.H., Fritz W.A., Moore R.W., Strerath M., Bushman W., et al. Retinoic acid induces prostatic bud formation. Dev Dyn (2008)
41. Gat U., DasGupta R., Degenstein L., and Fuchs E. De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell 95 (1998) 605-614
42. Liu F., Chu E.Y., Watt B., Zhang Y., Gallant N.M., Andl T., et al. Wnt/beta-catenin signaling directs multiple stages of tooth morphogenesis. Dev Biol 313 (2008) 210-224
43. Teuliere J., Faraldo M.M., Deugnier M.A., Shtutman M., Ben-Ze'ev A., Thiery J.P., et al. Targeted activation of beta-catenin signaling in basal mammary epithelial cells affects mammary development and leads to hyperplasia. Development 132 (2005) 267-277
44. Zhang T.J., Hoffman B.G., Ruiz de Algara T., and Helgason C.D. SAGE reveals expression of Wnt signalling pathway members during mouse prostate development. Gene Expr Patterns 6 (2006) 310-324
45. Abbott B.D., and Birnbaum L.S. Cellular alterations and enhanced induction of cleft palate after coadministration of retinoic acid and TCDD. Toxicol Appl Pharmacol 99 (1989) 287-301
46. Birnbaum L.S., Harris M.W., Stocking L.M., Clark A.M., and Morrissey R.E. Retinoic acid and 2,3,7,8-tetrachlorodibenzo-p-dioxin selectively enhance teratogenesis in C57BL/6N mice. Toxicol Appl Pharmacol 98 (1989) 487-500
47. Kohl F.V., and Rudiger H.W. Retinoids inhibit 2,3,7,8-tetrachlorodibenzo-p-dioxine-induced activity of benzo[a]pyrene metabolizing enzymes in human diploid fibroblasts. Carcinogenesis 1 (1980) 733-737
48. Weston W.M., Nugent P., and Greene R.M. Inhibition of retinoic-acid-induced gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem Biophys Res Commun 207 (1995) 690-694
49. Vezina C.M., Hicks S.M., Moore R.W., and Peterson R.E. TCDD modulates selected developmental signaling pathways during mouse prostate morphogenesis. Organohalogen Compounds 69 (2007) 629-632
50. Vezina C.M., Li H., Goldberg M.C., Kim K.H., and Peterson R.E. Modulation of retinoic acid signaling may contribute to impairment of ventral prostatic bud formation by TCDD in the urogenital sinus of male fetal mice. The 45th Annual Meeting of the Society of Toxicology. San Diego, CA. Toxicologist (Suppl Toxicol Sci) 90 (2006) 923
51. Cardoso W.V., and Lu J. Regulation of early lung morphogenesis: questions, facts and controversies. Development 133 (2006) 1611-1624
52. Mikkola M.L., and Millar S.E. The mammary bud as a skin appendage: unique and shared aspects of development. J Mammary Gland Biol Neoplasia 11 (2006) 187-203
53. Salazar-Ciudad I. Tooth morphogenesis in vivo, in vitro, and in silico. Curr Top Dev Biol 81 (2008) 341-371
54. Tucker A.S. Salivary gland development. Semin Cell Dev Biol 18 (2007) 237-244
55. Warburton D., Bellusci S., De Langhe S., Del Moral P.M., Fleury V., Mailleux A., et al. Molecular mechanisms of early lung specification and branching morphogenesis. Pediatr Res 57 (2005) 26R-37R
56. Fenton S.E., Hamm J.T., Birnbaum L.S., and Youngblood G.L. Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci 67 (2002) 63-74
57. Kiukkonen A., Sahlberg C., Partanen A.M., Alaluusua S., Pohjanvirta R., Tuomisto J., et al. Interference by 2,3,7,8-tetrachlorodibenzo-p-dioxin with cultured mouse submandibular gland branching morphogenesis involves reduced epidermal growth factor receptor signaling. Toxicol Appl Pharmacol 212 (2006) 200-211
58. Kransler K.M., Tonucci D.A., McGarrigle B.P., Napoli J.L., and Olson J.R. Gestational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin alters retinoid homeostasis in maternal and perinatal tissues of the Holtzman rat. Toxicol Appl Pharmacol 224 (2007) 29-38
59. Miettinen H.M., Alaluusua S., Tuomisto J., and Viluksela M. Effect of in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on rat molar development: the role of exposure time. Toxicol Appl Pharmacol 184 (2002) 57-66
60. Prins G.S., Birch L., Tang W.Y., and Ho S.M. Developmental estrogen exposures predispose to prostate carcinogenesis with aging. Reprod Toxicol 23 (2007) 374-382
61. Rajfer J., and Coffey D.S. Sex steroid imprinting of the immature prostate. Long-term effects. Invest Urol 16 (1978) 186-190
62. Schulman C.C. The aging male: a challenge for urologists. Curr Opin Urol 10 (2000) 337-342
63. Fritz W.A., Lin T.M., Moore R.W., Cooke P.S., and Peterson R.E. In utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure: effects on the prostate and its response to castration in senescent C57BL/6J mice. Toxicol Sci 86 (2005) 387-395
64. Banerjee P.P., Banerjee S., Lai J.M., Strandberg J.D., Zirkin B.R., and Brown T.R. Age-dependent and lobe-specific spontaneous hyperplasia in the brown Norway rat prostate. Biol Reprod 59 (1998) 1163-1170
65. Kaplan-Lefko P.J., Chen T.M., Ittmann M.M., Barrios R.J., Ayala G.E., Huss W.J., et al. Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model. Prostate 55 (2003) 219-237
66. Shain S.A., McCullough B., and Segaloff A. Spontaneous adenocarcinomas of the ventral prostate of aged A X C rats. J Natl Cancer Inst 55 (1975) 177-180
67. Gingrich J.R., Barrios R.J., Morton R.A., Boyce B.F., DeMayo F.J., Finegold M.J., et al. Metastatic prostate cancer in a transgenic mouse. Cancer Res 56 (1996) 4096-4102
68. Shappell S.B., Thomas G.V., Roberts R.L., Herbert R., Ittmann M.M., Rubin M.A., et al. Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee. Cancer Res 64 (2004) 2270-2305
69. Fritz W.A., Lin T.M., Cardiff R.D., and Peterson R.E. The aryl hydrocarbon receptor inhibits prostate carcinogenesis in TRAMP mice. Carcinogenesis 28 (2007) 497-505
70. Loaiza-Perez A.I., Trapani V., Hose C., Singh S.S., Trepel J.B., Stevens M.F., et al. Aryl hydrocarbon receptor mediates sensitivity of MCF-7 breast cancer cells to antitumor agent 2-(4-amino-3-methylphenyl) benzothiazole. Mol Pharmacol 61 (2002) 13-19
71. Endo F., Monsees T.K., Akaza H., Schill W.B., and Pflieger-Bruss S. Effects of single non-ortho, mono-ortho, and di-ortho chlorinated biphenyls on cell functions and proliferation of the human prostatic carcinoma cell line, LNCaP. Reprod Toxicol 17 (2003) 229-236
72. Jana N.R., Sarkar S., Ishizuka M., Yonemoto J., Tohyama C., and Sone H. Comparative effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on MCF-7, RL95-2, and LNCaP cells: role of target steroid hormones in cellular responsiveness to CYP1A1 induction. Mol Cell Biol Res Commun 4 (2000) 174-180
73. Kizu R., Okamura K., Toriba A., Kakishima H., Mizokami A., Burnstein K.L., et al. A role of aryl hydrocarbon receptor in the antiandrogenic effects of polycyclic aromatic hydrocarbons in LNCaP human prostate carcinoma cells. Arch Toxicol 77 (2003) 335-343
74. Fukuzawa N.H., Ohsako S., Wu Q., Sakaue M., Fujii-Kuriyama Y., Baba T., et al. Testicular cytochrome P450scc and LHR as possible targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the mouse. Mol Cell Endocrinol 221 (2004) 87-96
75. Lin T.-M., Fritz W.A., and Peterson R.E. Evidences that null expression of aryl-hydrocarbon receptor (AhR) and in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure increase susceptibility to prostate cancer in adulthood. The fetal basis of adult disease grantee meeting. Durham, NC (2005)
76. Jenkins S., Rowell C., Wang J., and Lamartiniere C.A. Prenatal TCDD exposure predisposes for mammary cancer in rats. Reprod Toxicol 23 (2007) 391-396
77. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies). Natl Toxicol Program Tech Rep Ser 2006:4-232.
78. Kociba R.J., Keyes D.G., Beyer J.E., Carreon R.M., Wade C.E., Dittenber D.A., et al. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol 46 (1978) 279-303
79. Oenga G.N., Spink D.C., and Carpenter D.O. TCDD and PCBs inhibit breast cancer cell proliferation in vitro. Toxicol In Vitro 18 (2004) 811-819
80. Bertazzi P.A., Zocchetti C., Guercilena S., Consonni D., Tironi A., Landi M.T., et al. Dioxin exposure and cancer risk: a 15-year mortality study after the "Seveso accident". Epidemiology 8 (1997) 646-652
81. Warner M., Eskenazi B., Mocarelli P., Gerthoux P.M., Samuels S., Needham L., et al. Serum dioxin concentrations and breast cancer risk in the Seveso Women's Health Study. Environ Health Perspect 110 (2002) 625-628
82. Pavuk M., Michalek J.E., and Ketchum N.S. Prostate cancer in US Air Force veterans of the Vietnam war. J Expo Sci Environ Epidemiol 16 (2006) 184-190
83. Gupta A., Ketchum N., Roehrborn C.G., Schecter A., Aragaki C.C., and Michalek J.E. Serum dioxin, testosterone, and subsequent risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans. Environ Health Perspect 114 (2006) 1649-1654
84. Gupta A., Schecter A., Aragaki C.C., and Roehrborn C.G. Dioxin exposure and benign prostatic hyperplasia. J Occup Environ Med 48 (2006) 708-714
85. Hsu E.L., Yoon D., Choi H.H., Wang F., Taylor R.T., Chen N., et al. A proposed mechanism for the protective effect of dioxin against breast cancer. Toxicol Sci 98 (2007) 436-444
86. Safe S., Qin C., and McDougal A. Development of selective aryl hydrocarbon receptor modulators for treatment of breast cancer. Expert Opin Investig Drugs 8 (1999) 1385-1396
87. Fritz W.A., Lin T.M., Safe S., and Peterson R.E. Activation of aryl hydrocarbon receptor (AhR) by the selective modulator 6-methyl-1,3,8-trichlorodibenzofuran (6-MCDF) protects against prostate tumor progression in TRAMP mice. Proc Amer Assoc Cancer Res A. Anaheim, CA (2005)
88. Marks L.S., Mostaghel E.A., and Nelson P.S. Prostate tissue androgens: history and current clinical relevance. Urology 72 (2008) 247-254
89. Moore R.W., Jefcoate C.R., and Peterson R.E. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits steroidogenesis in the rat testis by inhibiting the mobilization of cholesterol to cytochrome P450scc. Toxicol Appl Pharmacol 109 (1991) 85-97
90. Safe S., Wang F., Porter W., Duan R., and McDougal A. Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. Toxicol Lett 102-103 (1998) 343-347
91. Hanus M., and Matouskova M. [Antiestrogens (tamoxifen) in the alternative therapy of benign prostatic hyperplasia]. Rozhl Chir 72 (1993) 316-318
92. Ricke W.A., McPherson S.J., Bianco J.J., Cunha G.R., Wang Y., and Risbridger G.P. Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signalling. Faseb J 22 (2008) 1512-1520
93. De Marzo A.M., Platz E.A., Sutcliffe S., Xu J., Gronberg H., Drake C.G., et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 7 (2007) 256-269
94. Dooley R.K., and Holsapple M.P. Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: I. The role of the B lymphocyte. Immunopharmacology 16 (1988) 167-180
95. Shukla S., Maclennan G.T., Marengo S.R., Resnick M.I., and Gupta S. Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model. Prostate 64 (2005) 224-239
96. Huss W.J., Hanrahan C.F., Barrios R.J., Simons J.W., and Greenberg N.M. Angiogenesis and prostate cancer: identification of a molecular progression switch. Cancer Res 61 (2001) 2736-2743
97. Fritz W.A., Lin T.M., and Peterson R.E. The aryl hydrocarbon receptor (AhR) inhibits vanadate-induced vascular endothelial growth factor (VEGF) production in TRAMP prostates. Carcinogenesis 29 (2008) 1077-1082
98. Lin T.-L., Hopkins W.J., Torrealba J.R., Briggs P.M., Roenneburg D.A., Fritz W., et al. Development of prostate dysplasia following transient prostatitis in C57Bl/6J mice: Lack of effect of aryl hydrocarbon receptor (AhR) genotype (2007), American Association for Cancer Research. American Association for Cancer Research, Los Angeles, CA